| 摘要 |
<p>A PHARMACEUTICAL COMPOSITION ABSTRACT The present invention relates to a pharmaceutical composition including loratidine, its use in the treatment of upper respiratory mucosal congestion and a method of administration of the composition. Particularly, though not exclusively, the invention relates to a pharmaceutical composition including loratidine in an amount suitable for administration a maximum of 4 times a day, and a second active that is a hydroxyl-a-[(methylamino) methyl]-benzenemethanol, such 3-hydroxyl-a-[(methylamino) methyl]-benzenemethanol (phenylephrine), or salt thereof.</p> |
